Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81760544)
Scientific Research and Technology Development Program of Guangxi (Guike AB18221007)
Received: 19 September 2019
Accepted: 31 December 2019
First Online: 8 January 2020
Ethics approval and consent to participate
: The study on NPC cancer samples was approved and supervised by the Research Ethics Committee of Affiliated Tumor Hospital of Guangxi Medical University approved the study protocol. Written Informed Consents were obtained from all patients. The animal experiments were performed in strict accordance with the guidelines of the Research Animal Care Committee of Affiliated Tumor Hospital of Guangxi Medical University.
: All authors agree on publication of the results of the present manuscript.
: The authors declare that they have no competing interests.